ANIP
ANI Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
5.63 / 10
Netural
Fund flow is strong (7.68/10) with positive small, medium and large inflows but negative block and extra‑large trends. Analyst consensus is a single Strong Buy, yet historical win‑rate is only 20% and average return –2.55%, indicating weak analyst confidence.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-16
InstitutionGuggenheim
Times predicted5
Historical Win Rate20.0%
What is the analyst consensus for ANIP?
- ANIP holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.63/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
